Copyright Reports & Markets. All rights reserved.

Global Morphine Sulfate Extended Release Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Morphine Sulfate Extended Release Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 10mg
    • 1.3.3 30mg
    • 1.3.4 60mg
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Morphine Sulfate Extended Release Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Morphine Sulfate Extended Release Tablets Market Size & Forecast
    • 1.5.1 Global Morphine Sulfate Extended Release Tablets Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Morphine Sulfate Extended Release Tablets Sales Quantity (2021-2032)
    • 1.5.3 Global Morphine Sulfate Extended Release Tablets Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 NAPP PHARMACEUTICALS LIMITED
    • 2.1.1 NAPP PHARMACEUTICALS LIMITED Details
    • 2.1.2 NAPP PHARMACEUTICALS LIMITED Major Business
    • 2.1.3 NAPP PHARMACEUTICALS LIMITED Morphine Sulfate Extended Release Tablets Product and Services
    • 2.1.4 NAPP PHARMACEUTICALS LIMITED Morphine Sulfate Extended Release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 NAPP PHARMACEUTICALS LIMITED Recent Developments/Updates
  • 2.2 Purdue Pharma
    • 2.2.1 Purdue Pharma Details
    • 2.2.2 Purdue Pharma Major Business
    • 2.2.3 Purdue Pharma Morphine Sulfate Extended Release Tablets Product and Services
    • 2.2.4 Purdue Pharma Morphine Sulfate Extended Release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Purdue Pharma Recent Developments/Updates
  • 2.3 Mallinckrodt Pharmaceuticals
    • 2.3.1 Mallinckrodt Pharmaceuticals Details
    • 2.3.2 Mallinckrodt Pharmaceuticals Major Business
    • 2.3.3 Mallinckrodt Pharmaceuticals Morphine Sulfate Extended Release Tablets Product and Services
    • 2.3.4 Mallinckrodt Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
  • 2.4 Teva Pharmaceuticals
    • 2.4.1 Teva Pharmaceuticals Details
    • 2.4.2 Teva Pharmaceuticals Major Business
    • 2.4.3 Teva Pharmaceuticals Morphine Sulfate Extended Release Tablets Product and Services
    • 2.4.4 Teva Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Teva Pharmaceuticals Recent Developments/Updates
  • 2.5 Viatris
    • 2.5.1 Viatris Details
    • 2.5.2 Viatris Major Business
    • 2.5.3 Viatris Morphine Sulfate Extended Release Tablets Product and Services
    • 2.5.4 Viatris Morphine Sulfate Extended Release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Viatris Recent Developments/Updates
  • 2.6 Allergan
    • 2.6.1 Allergan Details
    • 2.6.2 Allergan Major Business
    • 2.6.3 Allergan Morphine Sulfate Extended Release Tablets Product and Services
    • 2.6.4 Allergan Morphine Sulfate Extended Release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Allergan Recent Developments/Updates
  • 2.7 Rhodes Pharmaceuticals
    • 2.7.1 Rhodes Pharmaceuticals Details
    • 2.7.2 Rhodes Pharmaceuticals Major Business
    • 2.7.3 Rhodes Pharmaceuticals Morphine Sulfate Extended Release Tablets Product and Services
    • 2.7.4 Rhodes Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Rhodes Pharmaceuticals Recent Developments/Updates
  • 2.8 West-Ward Pharmaceuticals
    • 2.8.1 West-Ward Pharmaceuticals Details
    • 2.8.2 West-Ward Pharmaceuticals Major Business
    • 2.8.3 West-Ward Pharmaceuticals Morphine Sulfate Extended Release Tablets Product and Services
    • 2.8.4 West-Ward Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 West-Ward Pharmaceuticals Recent Developments/Updates

3 Competitive Environment: Morphine Sulfate Extended Release Tablets by Manufacturer

  • 3.1 Global Morphine Sulfate Extended Release Tablets Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Morphine Sulfate Extended Release Tablets Revenue by Manufacturer (2021-2026)
  • 3.3 Global Morphine Sulfate Extended Release Tablets Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Morphine Sulfate Extended Release Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Morphine Sulfate Extended Release Tablets Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Morphine Sulfate Extended Release Tablets Manufacturer Market Share in 2025
  • 3.5 Morphine Sulfate Extended Release Tablets Market: Overall Company Footprint Analysis
    • 3.5.1 Morphine Sulfate Extended Release Tablets Market: Region Footprint
    • 3.5.2 Morphine Sulfate Extended Release Tablets Market: Company Product Type Footprint
    • 3.5.3 Morphine Sulfate Extended Release Tablets Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Morphine Sulfate Extended Release Tablets Market Size by Region
    • 4.1.1 Global Morphine Sulfate Extended Release Tablets Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Morphine Sulfate Extended Release Tablets Consumption Value by Region (2021-2032)
    • 4.1.3 Global Morphine Sulfate Extended Release Tablets Average Price by Region (2021-2032)
  • 4.2 North America Morphine Sulfate Extended Release Tablets Consumption Value (2021-2032)
  • 4.3 Europe Morphine Sulfate Extended Release Tablets Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Morphine Sulfate Extended Release Tablets Consumption Value (2021-2032)
  • 4.5 South America Morphine Sulfate Extended Release Tablets Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Morphine Sulfate Extended Release Tablets Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Morphine Sulfate Extended Release Tablets Sales Quantity by Type (2021-2032)
  • 5.2 Global Morphine Sulfate Extended Release Tablets Consumption Value by Type (2021-2032)
  • 5.3 Global Morphine Sulfate Extended Release Tablets Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Morphine Sulfate Extended Release Tablets Sales Quantity by Application (2021-2032)
  • 6.2 Global Morphine Sulfate Extended Release Tablets Consumption Value by Application (2021-2032)
  • 6.3 Global Morphine Sulfate Extended Release Tablets Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Morphine Sulfate Extended Release Tablets Sales Quantity by Type (2021-2032)
  • 7.2 North America Morphine Sulfate Extended Release Tablets Sales Quantity by Application (2021-2032)
  • 7.3 North America Morphine Sulfate Extended Release Tablets Market Size by Country
    • 7.3.1 North America Morphine Sulfate Extended Release Tablets Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Morphine Sulfate Extended Release Tablets Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Morphine Sulfate Extended Release Tablets Sales Quantity by Type (2021-2032)
  • 8.2 Europe Morphine Sulfate Extended Release Tablets Sales Quantity by Application (2021-2032)
  • 8.3 Europe Morphine Sulfate Extended Release Tablets Market Size by Country
    • 8.3.1 Europe Morphine Sulfate Extended Release Tablets Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Morphine Sulfate Extended Release Tablets Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Morphine Sulfate Extended Release Tablets Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Morphine Sulfate Extended Release Tablets Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Morphine Sulfate Extended Release Tablets Market Size by Region
    • 9.3.1 Asia-Pacific Morphine Sulfate Extended Release Tablets Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Morphine Sulfate Extended Release Tablets Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Morphine Sulfate Extended Release Tablets Sales Quantity by Type (2021-2032)
  • 10.2 South America Morphine Sulfate Extended Release Tablets Sales Quantity by Application (2021-2032)
  • 10.3 South America Morphine Sulfate Extended Release Tablets Market Size by Country
    • 10.3.1 South America Morphine Sulfate Extended Release Tablets Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Morphine Sulfate Extended Release Tablets Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Morphine Sulfate Extended Release Tablets Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Morphine Sulfate Extended Release Tablets Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Morphine Sulfate Extended Release Tablets Market Size by Country
    • 11.3.1 Middle East & Africa Morphine Sulfate Extended Release Tablets Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Morphine Sulfate Extended Release Tablets Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Morphine Sulfate Extended Release Tablets Market Drivers
  • 12.2 Morphine Sulfate Extended Release Tablets Market Restraints
  • 12.3 Morphine Sulfate Extended Release Tablets Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Morphine Sulfate Extended Release Tablets and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Morphine Sulfate Extended Release Tablets
  • 13.3 Morphine Sulfate Extended Release Tablets Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Morphine Sulfate Extended Release Tablets Typical Distributors
  • 14.3 Morphine Sulfate Extended Release Tablets Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Morphine Sulfate Extended Release Tablets market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Morphine Sulfate Extended Release Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Morphine Sulfate Extended Release Tablets market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Morphine Sulfate Extended Release Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Morphine Sulfate Extended Release Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Morphine Sulfate Extended Release Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Morphine Sulfate Extended Release Tablets
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Morphine Sulfate Extended Release Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include NAPP PHARMACEUTICALS LIMITED, Purdue Pharma, Mallinckrodt Pharmaceuticals, Teva Pharmaceuticals, Viatris, Allergan, Rhodes Pharmaceuticals, West-Ward Pharmaceuticals, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Morphine Sulfate Extended Release Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    10mg
    30mg
    60mg
    Market segment by Application
    Hospital
    Clinic
    Others
    Major players covered
    NAPP PHARMACEUTICALS LIMITED
    Purdue Pharma
    Mallinckrodt Pharmaceuticals
    Teva Pharmaceuticals
    Viatris
    Allergan
    Rhodes Pharmaceuticals
    West-Ward Pharmaceuticals
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Morphine Sulfate Extended Release Tablets product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Morphine Sulfate Extended Release Tablets, with price, sales quantity, revenue, and global market share of Morphine Sulfate Extended Release Tablets from 2021 to 2026.
    Chapter 3, the Morphine Sulfate Extended Release Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Morphine Sulfate Extended Release Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Morphine Sulfate Extended Release Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Morphine Sulfate Extended Release Tablets.
    Chapter 14 and 15, to describe Morphine Sulfate Extended Release Tablets sales channel, distributors, customers, research findings and conclusion.

    Buy now